Literature DB >> 21498396

Does stage II colorectal cancer need to be redefined?

Axel Grothey1.   

Abstract

Detection of guanylyl cyclase C mRNA in lymph nodes of resected stage II colorectal cancer is highly correlated with the risk of tumor recurrence. If validated, these results could have significant implications for the selection of patients for adjuvant therapy in this disease. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21498396     DOI: 10.1158/1078-0432.CCR-11-0574

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  3 in total

1.  Analytic lymph node number establishes staging accuracy by occult tumor burden in colorectal cancer.

Authors:  Terry Hyslop; David S Weinberg; Stephanie Schulz; Alan Barkun; Scott A Waldman
Journal:  J Surg Oncol       Date:  2012-01-17       Impact factor: 3.454

Review 2.  Guanylyl cyclase C as a biomarker in colorectal cancer.

Authors:  Terry Hyslop; Scott A Waldman
Journal:  Biomark Med       Date:  2013-02       Impact factor: 2.851

3.  Molecular staging of node negative patients with colorectal cancer.

Authors:  Terry Hyslop; Scott A Waldman
Journal:  J Cancer       Date:  2013-03-01       Impact factor: 4.207

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.